FDA Inspection 788281 — Wacker Biotech B.V.
The FDA completed an inspection of Wacker Biotech B.V. on Jun 7, 2012 in Amsterdam. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 7, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Amsterdam (Netherlands)